PubMed:10362840 / 0-95
Annnotations
Glycan-Motif
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 23-30 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T2 | 23-30 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 23-30 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-95 | Sentence | denotes | Structural features in heparin that interact with VEGF165 and modulate its biological activity. |
| T1 | 0-95 | Sentence | denotes | Structural features in heparin that interact with VEGF165 and modulate its biological activity. |
| T1 | 0-95 | Sentence | denotes | Structural features in heparin that interact with VEGF165 and modulate its biological activity. |
GlyCosmos6-Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 23-30 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T2 | 23-30 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
GlycoBiology-FMA
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| _T1 | 23-30 | FMAID:82839 | denotes | heparin |
| _T2 | 23-30 | FMAID:167420 | denotes | heparin |
GlycoBiology-Motifs
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 23-30 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |